Atraumatic Vestibular Stimulation and Measuring Electrode
A Marx, A De Marzo, R Saba - US Patent App. 15/550,503, 2018
… interest for the present purposes. US Pat. No. 7,962,217 of the Merfeld group
addresses Meniere's disease and is not intended for selective stimulation as required
for treatment of vestibular disease. The Merfeld group also has …
addresses Meniere's disease and is not intended for selective stimulation as required
for treatment of vestibular disease. The Merfeld group also has …
 |  |  |
Methods of inducing indolamine 2, 3-dioxygenase (ido)
L Salford, HO Sjogren, B Widegren - US Patent App. 15/785,075, 2018
… Bowel Diseases, Insulin resistance-type B, Lambert-Eaton Myasthenic Syndrome, Lens-induced
uveitis, Lichen Sclerosus et Atrophicus, Lupus Erythematosus Discoid, Lupus Erythematosus
Systemic, Lupus Hepatitis, Lupus Nephritis, Lymphopenia, Meniere's Disease, Mixed …
uveitis, Lichen Sclerosus et Atrophicus, Lupus Erythematosus Discoid, Lupus Erythematosus
Systemic, Lupus Hepatitis, Lupus Nephritis, Lymphopenia, Meniere's Disease, Mixed …
| | |
A Trend in Sudden Sensorineural Hearing Loss: Data from a Population-Based Study
SH Kim, SJ Kim, H Im, TH Kim, JJ Song, SW Chae - Audiology and Neurotology, 2017
… It was a population-based, retrospective study that enrolled patients with unilateral SSNHL based
on national health insurance data, so there was a possible enrollment of acute, low-frequency
sensorineural hearing loss and Meniere's disease among the cases diagnosed with …
on national health insurance data, so there was a possible enrollment of acute, low-frequency
sensorineural hearing loss and Meniere's disease among the cases diagnosed with …
| | |
[PDF] Optimum Number of Sweeps in Clinical OVEMP Recording; How Many Sweeps are Necessary?
A Mallinson, A Kuijpers, N Longridge - 2018
… Clin Neurophysiol 2013; 124: 785-91. [CrossRef ] 9. Winters SM, Campschroer T, Grolman
W, Klis SF. Ocular vestibular evoked myogenic potentials in response to air-conducted sound
in Meniere's disease. Otol Neurotol 2011; 32: 1273-80. [CrossRef ] 10 …
W, Klis SF. Ocular vestibular evoked myogenic potentials in response to air-conducted sound
in Meniere's disease. Otol Neurotol 2011; 32: 1273-80. [CrossRef ] 10 …
| | |
[PDF] Hormone replacement therapy decreases the risk of tinnitus in menopausal women–a nationwide study
HC Chen, CH Chung, VCF Chen, YC Wang, WC Chien - women
… With 0.000 - - 0.598 0.000 - - 0.606 Meniere's disease Without Reference Reference With 0.000 - -
0.442 0.000 - - 0.465 … With 0 308.15 0.00 0 1, 144.96 0.00 - - - - - Meniere's disease Without 60 84,
573.38 70.94 246 260, 213.41 94.54 0.750 0.504 0.345 0.759 0.001 …
0.442 0.000 - - 0.465 … With 0 308.15 0.00 0 1, 144.96 0.00 - - - - - Meniere's disease Without 60 84,
573.38 70.94 246 260, 213.41 94.54 0.750 0.504 0.345 0.759 0.001 …
| | |
Embryo‐fetal development studies with the dietary supplement vinpocetine in the rat and rabbit
N Catlin, S Waidyanatha, E Mylchreest, L Miller‐Pinsler… - Birth Defects Research
… Other reported uses include treatment for vertigo, urinary incontinence, tinnitus, Meniere's disease,
visual impairment, menopause symptoms, chronic fatigue syndrome, seizure disorders, and for
prevention of motion sickness (Anonymous, 1984; Sitges, 2016; Taiji & Kanzaki …
visual impairment, menopause symptoms, chronic fatigue syndrome, seizure disorders, and for
prevention of motion sickness (Anonymous, 1984; Sitges, 2016; Taiji & Kanzaki …
| | |
Perspectives On Western Art, Vol. 1: Source Documents And Readings From The Ancient Near East Through The Middle Ages
L Wren - 2018
| | |
Fabry disease: Clinical features and diagnosis
M Mauer, JB Kopp, R Schiffmann, RJ Glassock
Fabry disease, also called Anderson-Fabry disease, is the most prevalent lysosomal storage
disorder. It is an X-linked inborn error of the glycosphingolipid met.
disorder. It is an X-linked inborn error of the glycosphingolipid met.
| | |
Targeting oligonucleotides and uses thereof to modulate gene expression
F Ozsolak - US Patent App. 15/550,103, 2018
Aspects of the invention provide single stranded oligonucleotides for modulating expression
of genes based on targeting of low abundance non-coding RNA transcripts. Further aspects
provide compositions and kits comprising single stranded oligonucleotides for modulating …
of genes based on targeting of low abundance non-coding RNA transcripts. Further aspects
provide compositions and kits comprising single stranded oligonucleotides for modulating …
| | |
Modifications of therapeutic agents for enhanced delivery to target sites
D Kolb, P Ledin, T Mizuhara - US Patent App. 15/660,256, 2018
Compositions of a modulator of cell metabolism, typically targeting cellular glycolysis, preferably
with a targeting moiety, attached directly or indirectly to the inhibitor, or to a nanoparticle or other
delivery vehicle thereof, and methods of use for treating cancer, proliferative disorders …
with a targeting moiety, attached directly or indirectly to the inhibitor, or to a nanoparticle or other
delivery vehicle thereof, and methods of use for treating cancer, proliferative disorders …
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου